UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 17, 2021

DHB Capital Corp.

(Exact name of registrant as specified in its charter)

5 Brewster Street #2105

Glen Cove, NY 11542

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (646) 450-5664

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01. Other Events.

As previously reported on a Current Report on Form 8-K of DHB Capital Corp. (the “Company”), on March 4, 2021, the Company consummated its initial public offering (the “IPO”) of 25,000,000 units (the “Units”). Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), and one-third of one redeemable warrant of the Company (the “Warrants”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $250,000,000. The Company had granted the underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments, if any.

On March 15, 2021, the Underwriters exercised their over-allotment option in full, and the closing of the issuance and sale of the additional 3,750,000 Units (the “Over-Allotment Units”) occurred on March 17, 2021, generating gross proceeds of $37,500,000.

As previously reported on a Current Report on Form 8-K of the Company, on March 4, 2021, simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of an aggregate of 4,666,667 Warrants (the “Private Placement Warrants”) to DHB Capital LLC (the “Sponsor”) at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $7,000,000. In connection with the closing of the purchase of the Over-Allotment Units, the Company sold an additional 500,000 Private Placement Warrants to the Sponsor at a price of $1.50 per Private Placement Warrant, generating an additional $750,000 of gross proceeds.

An audited balance sheet as of March 4, 2021 reflecting receipt of the net proceeds from the IPO and the sale of the Private Placement Warrants on March 4, 2021, but not the proceeds from the sale of the Over-Allotment Units on March 17, 2021, had been filed on a Current Report on Form 8-K on March 10, 2021.

A copy of the press release issued by the Company announcing the exercise of the over-allotment option is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statement and Exhibits.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: March 18, 2021